Clinical Trials Logo

Wild-type Amyloid Cardiopathy clinical trials

View clinical trials related to Wild-type Amyloid Cardiopathy.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04828928 Completed - Clinical trials for Wild-type Amyloid Cardiopathy

Neuropathy in Patients Monitored for Wild-type TTR Cardiac Amyloidosis (Non-mutated)

N-SAC
Start date: March 23, 2021
Phase: N/A
Study type: Interventional

Transthyretin (TTR) amyloidosis is a rare disabling disorder that can be hereditary or sporadic. Depending on the form, various tissues are affected. While in hereditary cases, neuropathy is predominant, cardiac impairment is the main manifestation in the sporadic form. The main objective of this project is to evaluate the proportion of patients with neuropathy in a population of patients with a non-mutated TTR amyloid cardiopathy condition.